Ziwei Wang
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Rehabilitation top 10%
- Stroke Rehabilitation and Recovery
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 3
- Lung Cancer Research Studies 3
- Co-authors
- Shrujal S. Baxi (1 shared paper)Deborah Korenstein (1 shared paper)Niloufer Khan (1 shared paper)Renee L. Gennarelli (1 shared paper)Lindsay Boyce (1 shared paper)Annie Yang (1 shared paper)Qiang Wang (1 shared paper)Lu Luo (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)OncoTargets and Therapy (2 papers)International Journal of COPD (2 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Ziwei Wang
35 papers receiving 728 citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 389
- Rehabilitation 40
- Immunology 117
- Pulmonary and Respiratory Medicine 129
- Geriatrics and Gerontology 13
Countries citing papers authored by Ziwei Wang
This map shows the geographic impact of Ziwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwei Wang more than expected).
Fields of papers citing papers by Ziwei Wang
This network shows the impact of papers produced by Ziwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwei Wang. The network helps show where Ziwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ziwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis Hit paper breakdown → | 2018 | 436 |
| 2 | 2022 | 70 | |
| 3 | 2019 | 61 | |
| 4 | 2016 | 22 | |
| 5 | 2024 | 18 | |
| 6 | 2017 | 18 | |
| 7 | 2024 | 10 | |
| 8 | 2021 | 8 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 7 | |
| 11 | 2023 | 7 | |
| 12 | 2021 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2024 | 3 |
About Ziwei Wang
Ziwei Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Physiology, having authored 44 papers that have together received 736 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Research Studies (3 papers), Frailty in Older Adults (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cancer therapeutics and mechanisms (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Oncology (389 citations), Rehabilitation (40 citations), Immunology (117 citations), Pulmonary and Respiratory Medicine (129 citations) and Geriatrics and Gerontology (13 citations). Ziwei Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Shrujal S. Baxi, Deborah Korenstein, Niloufer Khan, Renee L. Gennarelli, Lindsay Boyce, Annie Yang, Qiang Wang, Lu Luo, Fang Geng and Xingtao Zhou. Their work appears in journals such as Frontiers in Oncology, OncoTargets and Therapy, International Journal of COPD, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.